NIF is pleased to announce that planning is underway for this year’s Annual Scientific Meeting, Australia’s flagship event for advanced imaging research and innovation. Dates: 30 July 2026, with c
05 February 2026
Donanemab, developed by Lilly, is the first disease-modifying treatment for early-stage Alzheimer’s disease to be approved for use in Australia. The National Imaging Facility supported its developme
16 June 2025
A new national-scale molecular-imaging network that aims to improve cancer imaging, dementia diagnosis and treatment, and new radiopharmaceuticals was launched Saturday at the annual meeting for Austr
26 May 2025
The Commonwealth Government Department of Education has today announced National Imaging Facility (NIF) will receive $28m under the National Collaborative Research Infrastructure Strategy (NCRIS), to
19 October 2023